Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XaPPP: Xylitol and the Prevention of Periodontal Disease and Preterm Birth
NCT07424846Phase 3Recruiting
- Sponsor
- University of Washington
- Start
- Mar 2026
- Primary completion
- Sep 2030
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of xylitol in preterm birth, low birth weight (LBW), periodontitis and 2 more (3 arms), sponsored by University of Washington. Primary endpoints: Preterm Birth and Low birthweight offspring. Started Mar 2026; status: recruiting.
02
Drugs
xylitol
03
Conditions
preterm birthlow birth weight (LBW)periodontitisgingivitisDevelopmental delay
Beyond the preview
Go deeper on NCT07424846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07424846.